It currently remains unclear whether the selective inhibition of PDGFR is sufficient to reduce pulmonary fibrosis by targeting a single molecule, and also if PDGFR-α or -β is a better target for reducing fibrogenesis in the lungs. Here, PDGFRB is linked to pulmonary fibrosis.